\-\ Texto\\:\\ \ \(0\)\
\-\ normal\\ pap\\ and\\ pelvic\\ exam\\.\ \(0\)\
\-\ patient\\ was\\ refered\\ back\\ to\\ clinician\\ to\\ be\\ evaluated\\ for\\ endometrial\\ biopsy\ \(0\)\
\-\ on\\ transabdominal\\ ultrasound\\ imaging\\ there\\ was\\ a\\ normal\\ homogeneous\\ appearance\\ to\\ the\\ uterus\\ and\\ endometrial\\ stripe\\.\\ \\ no\\ endometrial\\ fluid\\ or\\ focal\\ areas\\ of\\ thickening\\.\\ \\ ems\\ measured\\ \\ 1\\.8\\ mm\\ consistent\\ with\\ endometrial\\ atrophy\\.\ \(0\)\
\-\ \\ \\ \\ \\ endovaginal\\ images\\ again\\ demonstrate\\ normal\\,\\ uniform\\ thickness\\ of\\ the\\ endometrial\\ stripe\\ without\\ focal\\ lesion\\.\\ \\ ems\\ measured\\ 1\\.9\\ mm\\.\ \(0\)\
\-\ \\ \\ \\ \\ hysterosonogram\\ initially\\ showed\\ no\\ focal\\ lesion\\ with\\ instillation\\ of\\ the\\ saline\\.\\ \\ after\\ balloon\\ was\\ deflated\\ a\\ small\\,\\ well\\ circumscribed\\ mass\\ was\\ identified\\ where\\ the\\ balloon\\ was\\ initially\\ sitting\\.\\ \\ this\\ lesion\\ is\\ a\\ homogeneous\\ echogenic\\ broad\\ based\\ thickening\\ of\\ the\\ endometrial\\ lining\\.\\ \\ it\\ measures\\ 5\\.1\\ x\\ 3\\.8\\ mm\\ and\\ demonstrates\\ smoothly\\ marginated\\ borders\\ without\\ cystic\\ components\\.\\ \\ the\\ cervical\\ canal\\ was\\ normal\\ in\\ appearance\\.\ \(0\)\
\-\ endometrial\\ atrophy\\ with\\ polyp\ \(0\)\
\-\ ddx\\ of\\ postmenopausal\\ bleeding\\:\ \(0\)\
\-\ 1\\)\\ \\ \\ endometrial\\ atrophy\\ \ \(0\)\
\-\ 2\\)\\ \\ \\ endometrial\\ polyp\\ \ \(0\)\
\-\ 3\\)\\ \\ \\ endometrial\\ carcinoma\ \(0\)\
\-\ 4\\)\\ \\ \\ endometrial\\ hyperplasia\ \(0\)\
\-\ 5\\)\\ \\ \\ submucosal\\ fibroid\ \(0\)\
\-\ 64\\ y\\/o\\ postmenopausal\\ female\\ with\\ new\\ onset\\ of\\ bleeding\\ starting\\ 2\\ months\\ ago\\.\\ \\ not\\ taking\\ any\\ medications\\ currently\\.\\ \\ was\\ on\\ hrt\\ for\\ 3\\ yrs\\,\\ but\\ quit\\ approximately\\ 1\\ year\\ ago\\.\\ \\ no\\ pertinent\\ family\\ history\\.\ \(0\)\
\-\ see\\ factoid\\.\ \(59\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ endometrial\\:\\ 0\\.6903414299735632\ \(0\)\
\-\ atrophy\\:\\ 0\\.17438517700400655\ \(0\)\
\-\ postmenopausal\\:\\ 0\\.16952789851965083\ \(0\)\
\-\ ems\\:\\ 0\\.1504138836659138\ \(0\)\
\-\ was\\:\\ 0\\.14988917093135776\ \(0\)\
\-\ stripe\\:\\ 0\\.14126117946478997\ \(0\)\
\-\ mm\\:\\ 0\\.13191031814628365\ \(0\)\
\-\ balloon\\:\\ 0\\.1285073959900187\ \(0\)\
\-\ polyp\\:\\ 0\\.12512135208172684\ \(0\)\
\-\ measured\\:\\ 0\\.1211938367021473\ \(0\)\
\-\ focal\\:\\ 0\\.11025338833862122\ \(0\)\
\-\ homogeneous\\:\\ 0\\.10849568061803332\ \(0\)\
\-\ bleeding\\:\\ 0\\.10043546547625859\ \(0\)\
\-\ normal\\:\\ 0\\.10034352106614026\ \(0\)\
\-\ hysterosonogram\\:\\ 0\\.09825726818561142\ \(0\)\
\-\ deflated\\:\\ 0\\.09825726818561142\ \(0\)\
\-\ hrt\\:\\ 0\\.09825726818561142\ \(0\)\
\-\ initially\\:\\ 0\\.09636316619550248\ \(0\)\
\-\ ago\\:\\ 0\\.0899098598804883\ \(0\)\
\-\ lesion\\:\\ 0\\.0883683068501833\ \(0\)\
\-\ instillation\\:\\ 0\\.08642428272900045\ \(0\)\
\-\ thickening\\:\\ 0\\.08359842058367646\ \(0\)\
\-\ refered\\:\\ 0\\.08205707987054367\ \(0\)\
\-\ endovaginal\\:\\ 0\\.07989568640583886\ \(0\)\
\-\ pap\\:\\ 0\\.07895850013084624\ \(0\)\
\-\ quit\\:\\ 0\\.07809637233054921\ \(0\)\
\-\ transabdominal\\:\\ 0\\.0758599203911488\ \(0\)\
\-\ appearance\\:\\ 0\\.07408059416593152\ \(0\)\
\-\ the\\:\\ 0\\.07355803521263089\ \(0\)\
\-\ of\\:\\ 0\\.07214219478287015\ \(0\)\
\-\ saline\\:\\ 0\\.07149271753269201\ \(0\)\
\-\ smoothly\\:\\ 0\\.07149271753269201\ \(0\)\
\-\ lining\\:\\ 0\\.07105303005381479\ \(0\)\
\-\ clinician\\:\\ 0\\.06945442080817833\ \(0\)\
\-\ starting\\:\\ 0\\.06908927236402501\ \(0\)\
\-\ yrs\\:\\ 0\\.06839413779299458\ \(0\)\
\-\ submucosal\\:\\ 0\\.06806270094922787\ \(0\)\
\-\ fibroid\\:\\ 0\\.06742893889484998\ \(0\)\
\-\ sitting\\:\\ 0\\.06654316487752382\ \(0\)\
\-\ without\\:\\ 0\\.06481545915081251\ \(0\)\
\-\ marginated\\:\\ 0\\.06472206950556823\ \(0\)\
\-\ uniform\\:\\ 0\\.06425369799500935\ \(0\)\
\-\ pertinent\\:\\ 0\\.06236660146536278\ \(0\)\
\-\ borders\\:\\ 0\\.061804516674687185\ \(0\)\
\-\ no\\:\\ 0\\.059939579630700686\ \(0\)\
\-\ taking\\:\\ 0\\.05951116630645164\ \(0\)\
\-\ ddx\\:\\ 0\\.058391108957321684\ \(0\)\
\-\ 64\\:\\ 0\\.05774595520697898\ \(0\)\
\-\ thickness\\:\\ 0\\.05701955545425435\ \(0\)\
\-\ echogenic\\:\\ 0\\.056339065137730966\ \(0\)\
\-\ hyperplasia\\:\\ 0\\.056014291361006746\ \(0\)\
\-\ components\\:\\ 0\\.055803091505372215\ \(0\)\
\-\ broad\\:\\ 0\\.05549385933232193\ \(0\)\
\-\ again\\:\\ 0\\.05480507736986889\ \(0\)\
\-\ uterus\\:\\ 0\\.05389174680237075\ \(0\)\
\-\ evaluated\\:\\ 0\\.05249737369854156\ \(0\)\
\-\ medications\\:\\ 0\\.051540970919734905\ \(0\)\
\-\ measures\\:\\ 0\\.05009392852987455\ \(0\)\
\-\ family\\:\\ 0\\.04833730890721799\ \(0\)\
\-\ where\\:\\ 0\\.0482851497373408\ \(0\)\
\-\ with\\:\\ 0\\.04812353315137492\ \(0\)\
\-\ pelvic\\:\\ 0\\.04802807673416773\ \(0\)\
\-\ circumscribed\\:\\ 0\\.047580263379740445\ \(0\)\
\-\ canal\\:\\ 0\\.04729174128373896\ \(0\)\
\-\ currently\\:\\ 0\\.0471972595592069\ \(0\)\
\-\ to\\:\\ 0\\.04608026292452512\ \(0\)\
\-\ based\\:\\ 0\\.04450607968111997\ \(0\)\
\-\ cervical\\:\\ 0\\.044005019685590195\ \(0\)\
\-\ identified\\:\\ 0\\.04355973841404985\ \(0\)\
\-\ biopsy\\:\\ 0\\.04306783341059757\ \(0\)\
\-\ factoid\\:\\ 0\\.04290873380391272\ \(0\)\
\-\ new\\:\\ 0\\.04250574861992198\ \(0\)\
\-\ areas\\:\\ 0\\.0417140648086642\ \(0\)\
\-\ back\\:\\ 0\\.04097660858188326\ \(0\)\
\-\ showed\\:\\ 0\\.0409239392958521\ \(0\)\
\-\ any\\:\\ 0\\.03970798546312392\ \(0\)\
\-\ onset\\:\\ 0\\.03945290503187971\ \(0\)\
\-\ approximately\\:\\ 0\\.0392037260475407\ \(0\)\
\-\ see\\:\\ 0\\.03821998923103075\ \(0\)\
\-\ and\\:\\ 0\\.03808798796408735\ \(0\)\
\-\ ultrasound\\:\\ 0\\.03789784641453042\ \(0\)\
\-\ for\\:\\ 0\\.03724449008058842\ \(0\)\
\-\ on\\:\\ 0\\.03711237255476427\ \(0\)\
\-\ cystic\\:\\ 0\\.03700372371155754\ \(0\)\
\-\ carcinoma\\:\\ 0\\.03675112944620708\ \(0\)\
\-\ months\\:\\ 0\\.0357635358092815\ \(0\)\
\-\ fluid\\:\\ 0\\.03547458367351882\ \(0\)\
\-\ consistent\\:\\ 0\\.033314630257954565\ \(0\)\
\-\ imaging\\:\\ 0\\.03228923720840455\ \(0\)\
\-\ demonstrate\\:\\ 0\\.031941386282070335\ \(0\)\
\-\ small\\:\\ 0\\.03169325107185733\ \(0\)\
\-\ it\\:\\ 0\\.03145070382615316\ \(0\)\
\-\ exam\\:\\ 0\\.030929346223956454\ \(0\)\
\-\ demonstrates\\:\\ 0\\.030867206546616316\ \(0\)\
\-\ but\\:\\ 0\\.030382588086153232\ \(0\)\
\-\ after\\:\\ 0\\.02980595543787811\ \(0\)\
\-\ well\\:\\ 0\\.029749954371354803\ \(0\)\
\-\ female\\:\\ 0\\.029648035913834796\ \(0\)\
\-\ images\\:\\ 0\\.028420475931089862\ \(0\)\
\-\ be\\:\\ 0\\.024924089806766508\ \(0\)\
\-\ there\\:\\ 0\\.024447116897856322\ \(0\)\
\-\ not\\:\\ 0\\.024255379470225453\ \(0\)\
\-\ history\\:\\ 0\\.023473955182354272\ \(0\)\
\-\ mass\\:\\ 0\\.02346875815087553\ \(0\)\
\-\ or\\:\\ 0\\.02137417187283152\ \(0\)\
\-\ this\\:\\ 0\\.021112176787238344\ \(0\)\
\-\ patient\\:\\ 0\\.019983618679077865\ \(0\)\
\-\ year\\:\\ 0\\.018934855162302127\ \(0\)\
\-\ is\\:\\ 0\\.016825989633893434\ \(0\)\
\-\ in\\:\\ 0\\.015284485321948704\ \(0\)\
